TITLE

Changes in the foveal microstructure after intravitreal bevacizumab application in patients with retinal vascular disease

AUTHOR(S)
Feucht, Nikolaus; Schönbach, Etienne Michael; Lanzl, Ines; Kotliar, Konstantin; Lohmann, Chris Patrick; Maier, Mathias
PUB. DATE
January 2013
SOURCE
Clinical Ophthalmology;2013, Vol. 7, p173
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Purpose: To investigate changes in the area of the foveal avascular zone (FAZ) in patients with retinal vascular disease. Patients and methods: This retrospective, consecutive study examined 53 eyes of 53 patients with macular edema due to branch retinal vein occlusion in 25 patients (47.2%) and nonproliferative diabetic retinopathy in 28 patients (52.8%). The macular edema was treated with an intravitreal injection of 0.05 mL equal to 1.25 mg bevacizumab. Before and 6-8 weeks after the injection, best corrected visual acuity, slit lamp biomicroscopy of the anterior segment and fundus, optical coherence tomography, and fluorescein angiography were conducted. The FAZ was manually circumscribed on early-phase angiography images and the area of the FAZ was measured. Results: The preoperative overall mean FAZ area was 0.327 ± 0.126 mm² (median 0.310 mm²). At the control consultation, the overall mean area was significantly larger (0.422 ± 0.259 mm²; median 0.380 mm²; P < 0.001). In the nonproliferative diabetic retinopathy subpopulation, the mean area was 0.361 ± 0.129 mm² (median 0.330 mm²) before bevacizumab application and 0.434 mm² at the follow-up visit (mean increase 0.071 mm²/19.7%). In the branch retinal vein occlusion group, the baseline FAZ area was 0.290 ± 0.115 mm² and 0.407 ± 0.350 mm² at follow-up (median 0.330 mm²; mean increase 0.117 mm²/40.3%). No cases of severe operation-associated complications were observed. Conclusion: The results confirm the safety of intravitreal bevacizumab injection in patients with macular edema due to nonproliferative diabetic retinopathy and branch retinal vein occlusion. The enlargement of the FAZ could be equivalent to an increase in retinal ischemia. These results may be transient; a potential vascular risk, however, when applying antivascular endothelial growth factor therapy in eyes with preexistent vascular disease must be considered.
ACCESSION #
85997305

 

Related Articles

  • Patient presents with type 2 diabetes, history of nonproliferative diabetic retinopathy. Weber, Charles H.; Telander, David G. // Ocular Surgery News;2/25/2012, Vol. 30 Issue 4, special section p5 

    The article describes the case of a patient presenting with an 18-year history of type II diabetes and an ocular history of nonproliferative diabetic retinopathy. It was revealed that the patient's clinical condition was consistent with lipedemic retinopathy with coexistent severe...

  • Current Concepts in Diabetic Retinopathy. Su Jeong Song; Tien Yin Wong // Diabetes & Metabolism Journal;Dec2014, Vol. 38 Issue 6, p416 

    For the past several decades, tremendous efforts have been made to decrease the complications of diabetes, including diabetic retinopathy. New diagnostic modalities like ultrawide field fundus fluorescein angiography and spectral domain optical coherence tomography has allowed more accurate...

  • Visualization and follow-up of acute macular neuroretinopathy with the Spectralis® HRA+OCT device. Neuhann, Irmingard M.; Inhoffen, Werner; Koerner, Sabine; Bartz-Schmidt, Karl Ulrich; Gelisken, Faik // Graefe's Archive of Clinical & Experimental Ophthalmology;Jul2010, Vol. 248 Issue 7, p1041 

    Acute macular neuroretinopathy (AMNR) is a rare disease entity, the diagnosis of which is frequently complicated by the subtlety of biomicroscopic findings. Two cases of AMNR are presented, in which the diagnosis and follow-up was enabled using the Spectralis® HRA+OCT in the absence of clear...

  • Microperimetry as a routine diagnostic test in the follow-up of retinal vein occlusion? Winterhalter, Sibylle; Lux, Anja; Maier, Anna; Scholz, Clara; Heußen, Florian; Huber, Klaudia; Joussen, Antonia // Graefe's Archive of Clinical & Experimental Ophthalmology;Feb2012, Vol. 250 Issue 2, p175 

    Background: In the follow-up of retinal vein occlusions, a patient's subjective change in vision frequently cannot be confirmed by objective measurements. Furthermore, contradictory results of OCT and distance visual acuity give the impression that current routine diagnostic tests might not be...

  • Impact of early rise of intraocular pressure on visual outcome following diabetic vitrectomy. Sharma, Yog Raj; Pruthi, Archna; Azad, Raj Vardhan; Kumar, Atul; Mannan, Rashim // Indian Journal of Ophthalmology;Jan2011, Vol. 59 Issue 1, p37 

    Objective: The objective was to study the incidence and risk factors for an early rise in intraocular pressure (IOP) following pars plana vitrectomy (PPV) for proliferative diabetic retinopathy (PDR) and to correlate its impact on visual outcome. Materials and Methods: This was a longitudinal...

  • Optical coherence tomography in progressive cone dystrophy. Zahlava, Jiri; Lestak, Jan; Karel, Ivan // Biomedical Papers of the Medical Faculty of Palacky University i;Dec2014, Vol. 158 Issue 4, p628 

    Aim. The aim of the study was to analyse different clinical pictures in patients with progressive cone dystrophy (PCD), to compare these with the results of optical coherence tomography (OCT) and to evaluate the benefits of this method for diagnosis. Methods. The group consisted of 16 patients...

  • Comparison of Optomap ultrawide-field imaging versus slit-lamp biomicroscopy for assessment of diabetic retinopathy in a real-life clinic. Purbrick, Robert M. J.; Izadi, Shahrnaz; Gupta, Ankur; Victor Chong, N. // Clinical Ophthalmology;2014, Vol. 8, p1413 

    Purpose: We aimed to assess the agreement between clinical assessment of diabetic retinopathy and Optomap ultrawide-field imaging (UWFI) in a real-life clinic setting. Methods: Structured examination findings, from diabetic patients attending routine medical retina clinics in July 2011, were...

  • A Study of the Preclinical Stages of Diabetic Retinopathy Using Multifocal Electroretinography. Elnahri, Gehad A.; Elsanabary, Zeinab S.; El Gohary, Amira M.; Ismaiel, Ghada A. // Egyptian Journal of Neurology, Psychiatry & Neurosurgery;Jul2014, Vol. 51 Issue 3, p255 

    Background: Diabetes-related eye disease is the most common cause of loss of vision in developed countries. Objective: To evaluate the changes of the multifocal electroretinography (mfERG) in the preclinical stage of diabetic retinopathy as a predictor of early onset of diabetic retinopathy....

  • Diyabetik Retinopati Seyrinde Optik Atrofi. Çitirik, Mehmet; Ertuğrul, Gökhan; Özkan, Seyhan Sonar; Taşdemir Ertuğrul, Gökçe; Zilelioğlu, Orhan // Retina-Vitreus/Journal of Retina-Vitreous;Mar2010, Vol. 18 Issue 1, p34 

    Purpose: To investigate the prevalence and the causes of optic atrophy in patients with diabetic retinopathy followed-up in our clinic. Materials and Methods: Thirty-two patients with diabetic retinopathy that were followed-up in Ministry of Health Ankara Ulucanlar Eye Hospital Retina Clinic...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics